Pain Management Therapeutics Market by Drug Class (Anesthetics, NSAIDS, Anticonvulsants, Antidepressants, Anti-migraine agents, Non-narcotic Analgesics, and Opioids (Tramadol, Oxycodone, Hydrocodone, and Others)); by Indication (Neuropathic Pain, Arthritic Pain, Cancer Pain, Post-operative Pain, Chronic Back Pain, Fibromyalgia, and Migraine), and by Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, and Online Pharmacy): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Global pain management therapeutics market expected to generate revenue of around USD 79,500 million by end of 2024, growing at a CAGR of around 4% between 2018 and 2024. The increasing incidence rates of cancer worldwide further contribute largely to the rise in demand for pain management therapeutics.

20-Sep-2018 | Number of pages: 130 | Report Code: ZMR-3373 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the pain management therapeutics market on a global and regional level. The study provides historic data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the pain management therapeutics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the pain management therapeutics market on a global level.

In order to give the users of this report a comprehensive view of the pain management therapeutics market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein drug class, indication, and distribution channel segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Pain Management Therapeutics Market

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research & development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, the product portfolio of various companies according to the region.

The study provides a decisive view of the pain management therapeutics market by segmenting the market based on drug class, indication, distribution channel, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. Based on drug class, the market is segmented into anesthetics, NSAIDS, anticonvulsants, antidepressants, anti-migraine agents, non-narcotic analgesics, opioids (tramadol, oxycodone, hydrocodone, and others). By indication, the market for pain management therapeutics market is segmented as neuropathic pain, arthritic pain, cancer pain, post-operative pain, chronic back pain, fibromyalgia, and migraine. Based on the distribution channel, the market is segmented as hospitals pharmacy, retail pharmacy, and online pharmacy. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further division into major countries including the U.S., Rest of North America, U.K., Germany, France, Italy, Spain, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, Brazil, Rest of Latin America, GCC Countries, South Africa, and Rest of Middle East and Africa. This segmentation includes demand for pain management therapeutics market based on individual drug class, indication, and distribution channel in all the regions and countries.

The report also includes detailed profiles of end players such as Pfizer Inc., Endo International Plc., Depomed, Inc., Purdue Pharma L.P., Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, AstraZeneca plc., Novartis AG, Merck & Co., Inc., Johnson & Johnson Services, Inc., GlaxoSmithKline Plc., and Abbott Laboratories, among others 

This report segments the global pain management therapeutics market as follows:

Global Pain Management Therapeutics Market: Drug Class Segment Analysis

  • Anesthetics
  • NSAIDS
  • Anticonvulsants
  • Antidepressants
  • Anti-migraine agents
  • Non-narcotic analgesics
  • Opioids
    • Tramadol
    • Oxycodone
    • Hydrocodone
    • Others

Global Pain Management Therapeutics Market: Indication Segment Analysis

  • Neuropathic Pain
  • Arthritic Pain
  • Cancer pain
  • Post-operative Pain
  • Chronic Back Pain
  • Fibromyalgia
  • A migraine    

Global Pain Management Therapeutics Market: Distribution Channel Segment Analysis

  • Hospitals Pharmacy 
  • Retail Pharmacy
  • Online Pharmacy 

Global Pain Management Therapeutics Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Related Reports

Hydroxychloroquine Market - By Type (USP Standards Grade, Pharmaceutical Standards Grade, EP Standards Grade, and Others), By Application (Rheumatoid Arthritis, Skin Lesions, Systemic Lupus Erythematosus, Chronic Discoid Lupus Erythematosus, and Others), and By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2025

Apr-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5346 | Report Format:

The global Hydroxychloroquine market value was estimated at 542 (USD Million) in 2019 and is projected to hit 5,000 (USD Million) by 2025 growing at a CAGR of over 33% during the period from 2019 to 2025. The report offers valuation and analysis of the Hydroxychloroquine market on a global as well...Read More

Hyperhidrosis Treatment Market: By Treatment Type (Botulinum Toxin A, Non-Surgical Microwave Energy Destruction of Sweat Glands, Iontophoresis, Topical Treatments, Surgical Treatments, and Others), By Type (Axillary Hyperhidrosis, Plantar Hyperhidrosis, Palmar Hyperhidrosis, and Others), and By End-User (Hospitals, Ambulatory Surgical Centers, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2025

Jan-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5214 | Report Format:

The report includes Revenue forecast analysis of the hyperhidrosis treatment market on a global as well as regional level. It also offers historic data of 2016 and 2017 and provides a valuation of the industry surge during 2019-2025 in terms of USD Billion. Our study includes competitive strategi...Read More

Home Blood Pressure Monitoring Devices Market: by Product (Upper Arm Monitors, Wrist Monitors, and Accessories), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Other Distribution Channels): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 - 2025

Dec-2019 | Price : $ 4199.00 | Pages: 130 | Report Code: ZMR-5131 | Report Format:

According to the report, global demand for home blood pressure monitoring devices market was valued at USD 1,093.1 million in 2018, and is expected to generate revenue of USD 1,611.3 million by end of 2025, growing at a CAGR of 5.7% between 2019 and 2025 The report covers forecast and analysis f...Read More

Orthostatic Hypotension Drugs Market: by Diagnostic Test Type (ECG, Blood Tests, Stress Test and Other), Drug Type (Midodrine, Northera (droxidopa), Fludrocortisone, Caffeine and Others) and End user (Hospitals, ASCs and Clinics and Others) – Global Industry Perspective Comprehensive Analysis and Forecast, 2019-2025

Dec-2019 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5123 | Report Format:

The report covers forecast and analysis for the Orthostatic Hypotension Drugs market on a global and regional level. The study provides historic data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the Orthosta...Read More

Carcinoembryonic Antigen Market: by Application (Thyroid Cancer, Prostate Cancer, Ovarian Cancer, Lung Cancer, Breast Cancer, Gastrointestinal Cancer and Other Applications); by End User (Research and Academic Institutes, Diagnostic Centers, Hospitals and Other End Users): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Dec-2019 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5122 | Report Format:

The report covers forecast and analysis for the carcinoembryonic antigen market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the carcinoembryonic antige...Read More

Request Brochure

COVID-19

A Global Pandemic

Request the coronavirus impact analysis across industries and market

Request impact analysis on this market
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.